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Abstract
Background: Although the cellular mechanisms responsible for the pathogenesis of autism are not understood, a
growing number of studies have suggested that localized inflammation of the central nervous system (CNS) may
contribute to the development of autism. Recent evidence shows that IL-6 has a crucial role in the development
and plasticity of CNS.
Methods: Immunohistochemistry studies were employed to detect the IL-6 expression in the cerebellum of study
subjects. In vitro adenoviral gene delivery approach was used to over-express IL-6 in cultured cerebellar granule
cells. Cell adhesion and migration assays, DiI labeling, TO-PRO-3 staining and immunofluorescence were used to
examine cell adhesion and migration, dendritic spine morphology, cell apoptosis and synaptic protein expression
respectively.
Results: In this study, we found that IL-6 was significantly increased in the cerebellum of autistic subjects. We
investigated how IL-6 affects neural cell development and function by transfecting cultured mouse cerebellar
granule cells with an IL-6 viral expression vector. We demonstrated that IL-6 over-expression in granule cells caused
impairments in granule cell adhesion and migration but had little effect on the formation of dendritic spines or
granule cell apoptosis. However, IL-6 over-expression stimulated the formation of granule cell excitatory synapses,
without affecting inhibitory synapses.
Conclusions: Our results provide further evidence that aberrant IL-6 may be associated with autism. In addition,
our results suggest that the elevated IL-6 in the autistic brain could alter neural cell adhesion, migration and also
cause an imbalance of excitatory and inhibitory circuits. Thus, increased IL-6 expression may be partially responsible
for the pathogenesis of autism.
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Background
Autistic disorder is the most severe of a group of neuro-
developmental disorders, referred to as autism spectrum
disorders (ASDs), and is characterized by problems in
communication, social skills, and repetitive behavior.
Susceptibility to autism is clearly attributable to genetic
factors [1-4], but the etiology of the disorder is
unknown. Recent studies suggest that a combination of
environmental risk factors, autoimmune conditions and
localized inflammation of the central nervous system
may contribute to the pathogenesis of autism [5-10].
Interleukin (IL)-6 was originally found to be a major
inducer of immune and inflammatory response [11].
Recent evidence points to a crucial role of IL-6 within
the central nervous system (CNS). In the CNS IL-6 can
trigger cellular responses mediating inflammation, neu-
rogenesis, gliogenesis, cell growth, cell survival, myelina-
tion and demyelination [12-16]. IL-6 is normally
expressed at relatively low levels in the brain [15]. How-
ever, in the presence of brain injury or inflammation,
IL-6 is elevated in the cerebral spinal fluid and brain
homogenates [13,14]. Chronic over-expression of IL-6 in
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siological alterations associated with neurological disease
[14,17]. IL-6 and leukaemia inhibitory factor were found
to promote astrocytic differentiation of neural stem⁄pro-
genitor cells [18]. Most recently, Oh et al demonstrated
that IL-6 promotes specific neuronal differentiation of
neural progenitor cells from the adult hippocampus [19].
Recent studies have reported an association of cyto-
kines with autism. TNF-a,I F N - g,I L - 1 b and IL-12 were
found to be elevated in blood mononuclear cells, serum
and plasma from autistic subjects [6,20-24]. Employing a
cytokine PCR array, Vargas et al [7] demonstrated that
IL-6, TNFa, transforming growth factor (TGF)-b1a n d
macrophage chemo-attractant protein (MCP)-1 were
increased in autistic brains. In addition, MCP-1, IL-8
and other proinflammatory molecules were also found
to be significantly elevated in the cerebrospinal fluid of
autistic children [7]. Consistent with the these findings,
our studies using a multiple bead immunoassay showed
that IL-6, TNFa,I L - 8 ,G M - C S Fa n dI F N g were signifi-
cantly increased in the fontal cortices of autistic subjects
as compared with the age-matched controls [5]. All
these findings suggest that the immune system and
cytokines may play important roles in the pathogenesis
of autism. However, the mechanisms by which immune
dysfunction and cytokine alteration contribute to the
pathogenesis of autism remain unknown. In this study,
we examined IL-6 in the cerebellum of autistic subjects.
Our results showed that IL-6 was significantly increased
in the cerebellum of autistic subjects as compared to
age-matched controls. In addition, we over-expressed
IL-6 in cerebral granule utilizing a viral construct
expression approach to study the effects of IL-6 on
neural cell properties and synapse formation. We further
demonstrated that IL-6 over-expression in granule cells
caused impairment in adhesion and migration. IL-6 had
little effect on the formation of dendritic spines or on
granule cell apoptosis. However IL-6 over-expression
stimulated the formation of granule cell excitatory
synapses, while having no effect on inhibitory synapses.
Our results provide further evidence for an association
of aberrant IL-6 expression with autism. Impaired neural
cell adhesion and migration, as well as the excessive for-
mation of excitatory synapse sc a u s e db ye l e v a t e dI L - 6
expression could be an underlying cellular mechanism
partially responsible for the pathogenesis of autism.
Methods
Study subjects
Frozen human brain tissues of six autistic subjects
(mean age 8.3 ± 3.8 years) and six age-matched normal
subjects (mean age 8 ± 3.7 years) were obtained from
the NICHD Brain and Tissue Bank for Developmental
Disorders (Baltimore, MD21201). Donors with autism fit
the diagnostic criteria of the Diagnostic and Statistical
Manual-IV, as confirmed by the Autism Diagnostic
Interview-Revised. Samples were excluded from the
study if they had a diagnosis of fragile X syndrome, epi-
leptic seizures, obsessive-compulsive disorder, affective
disorders, or any additional psychiatric or neurological
diagnoses. The subject information is summarized in
Additional file 1 Table S1.
Immunohistochemistry
Paraffin sections, 6 μm thick, from 10% formalin-fixed
cerebellar specimens from both autistic subjects and
control subjects were deparaffinized with Xylene and
ethanol and then washed with Tris [tris(hydroxymethyl)
aminomethane]-buffered saline (TBS). The sections were
then incubated with primary antibodies (IL-6, 1:100,
Abcam) overnight at 4°C. After washing in TBS for 5
min, the sections were further incubated with the sec-
ondary antibody (biotinylated horse anti-rabbit IgG,
VectaStain Elite ABC Kit, Vector Lab) for 30 min at RT,
followed by incubation in Avidin-biotinylated peroxidase
(VectaStain Elite ABC Kit) for 45 min at RT and in
0.0125 g DAB/25 ml 0.05 M TBS/1 drop 30% H2O2 for
10 min at RT. All sections were dehydrated with ethanol
and Xylene before mounting for examination by confo-
cal microscopy (Nikon Eclipse 90i, 10 × 40 magnifica-
tion). Image J analysis (National Institutes of Health,
Bethesda, MD, USA) was used to calculate areas and
immunostaining densities.
Cell culture
Cerebellar granule cells (CGCs) were prepared from
C57BL/6J mouse pups (5-6 days postnatal) as described
previously [25]. Briefly, the entire cerebellum was dis-
sected out, and single cell suspensions were prepared by
trypsinization and trituration. Cells were seeded into
PDL-coated dishes. After 24 h, the medium was
replaced with serum-free medium containing 15% N-2
supplement (Invitrogen) and 15 mM KCl.
In vitro adenoviral gene delivery
Mouse IL-6 GFP adenovirus (IL-6 group) and GFP ade-
novirus (Control group) were generated by Welgen
(Worcester, MA). After culturing for 4-5 days, CGCs
were infected with Ad-GFP-IL-6 or Ad-GFP at multipli-
city of infection (MOI) of 500. After 24 h, the medium
was replaced with normal growth medium. Three days
after infection, CGCs were used for the experiments
reported in the present study.
Cell adhesion assay
10, 000 CGCs were plated per well in 96 well tissue cul-
ture plates coated with recombinant ICAM-1 (inter-cellu-
lar adhesion molecule 1, R&D Systems) at the final
Wei et al. Journal of Neuroinflammation 2011, 8:52
http://www.jneuroinflammation.com/content/8/1/52
Page 2 of 10concentration of 10 μg/ml. After 1.5 h of attachment,
unattached cells were removed by aspiration and adherent
cells were quantitated by the colorimetric aqueous MTS
assay (CellTiter 96 AQueous One Solution kit, Promega).
Cell migration assay
CGCs were labeled with fluorescent Calcein AM (BD
Biosciences) at a final concentration of 2.5 μM. 10, 000
labeled cells were plated in 0.8 ml DMEM +1% FBS in
each well of 24 well chambers adapted for the HTS
Fluoroblock (BD Falcon) apparatus. After 3 h, 5% FBS
was added to the lower chamber medium to establish a
1-5% serum gradient. Migration of cells from the upper
to lower chamber were quantitated at 2 h using a
microfluorimetric plate reader (CytoFluor 4000, MTX
Lab Systems).
DiI labelling
The cultured cells were labeled using a protocol adapted
from Hering et al [26]. Briefly, CGCs were fixed in 4% for-
maldehyde for 15 min and incubated with Vybrant-DiI
cell-labeling solution (1:200, Invitrogen) for 25 min at 37°
C. Cultures were washed in warmed PBS, incubated in
PBS at 4°C for 24-48 h to allow dye diffusion within mem-
branes, mounted on glass slides with ProLong Gold anti-
fade reagent (Invitrogen), and then imaged using Nikon
Eclipse E800 microscope. Mature dendritic spines appear
mushroom or stubby-shaped morphology; while the
immature spines appear thin morphology [27,28]. For
quantification of the density of dendritic spines, a dendritic
protrusion with an expanded head that was 50% wider
than its neck was defined as a spine [29]. The number of
spines from one neuron was counted manually and nor-
malized per 50 μm dendritic length.
TO-PRO-3 Staining
To exam the apoptotic effect of IL-6 on CGCs, TO-
PRO-3 staining was used to visualize the nuclear mor-
phology of apoptotic cell. Cells that had bright con-
densed, fragmented nuclei after staining were
considered to be apoptotic [30,31]. To identify cells as
neurons, the culture was stained with anti-MAP2 poly-
clonal IgG (1:50, Cell Signaling Technology) and Alexa
Fluor 555-conjugated anti-rabbit IgG (Invitrogen). After
incubation with the secondary antibody, the CGCs were
stained with TO-PRO-3 iodide (final 1 mM; Invitrogen)
for 15 min, the cells were mounted and observed for
nuclear changes under a Nikon eclipse 90i confocal
laser scanning microscope. The maximal wavelength of
excitation/emission of the TO-PRO-3 dye is 642/661.
Lasers with excitation wavelengths of 633 nm were
applied to activate the far-red fluorescence which was
converted to blue under the laser confocal system. The
experiment was repeated for three times.
Immunofluorescence
CGCs were fixed in 4% formaldehyde for 15 min and
blocked with 3% goat serum/0.3% Triton X-100 in PBS
and incubated with anti-Syp polyclonal antibody (Synap-
tophysin, 1:200, Cell Signaling Technology), anti-
VGLUT1 monoclonal antibody (1:500, Millipore), and
anti-VGAT polyclonal antibody (1:500, Millipore) over-
night at 4°C, followed by incubation with Alexa Fluor
577 anti-mouse and anti-rabbit IgG (1:1000, Invitrogen)
for 1.5 h at room temperature. Cultures were mounted
on glass slides with ProLong Gold antifade reagent
(Invitrogen), and then imaged using Nikon eclipse 90i
confocal laser scanning microscope.
The analysis of immunofluorescence images were
done as described previously [32]. Images were acquired
in the linear range with constant settings and analyzed
using ImageJ software. All analyses were performed
blind to the treatment of the culture. Immunoreactive
puncta were defined as discrete regions along the den-
drite with fluorescence intensity twice the background
and average size of the puncta were normalized with
data from Ad-GFP group, respectively. For quantifica-
tion, 20-30 neurons from two to three different batches
of cultures and experiments for each condition were
randomly chosen on the basis of healthy morphology.
Negative controls, in which the primary antibodies were
omitted and treated only with the secondary antibodies,
were run for each condition to exclude false positive
secondary antibody binding. The n value refers to the
number of cells analyzed.
Statistics
We determined the statistical significance among groups
with the unpaired t test using the StatView 5.0 software
(SAS Institute, Inc.). A null hypothesis probability of
<0.05% was considered significant. All data are pre-
sented as means ± standard error (SEM).
Results
IL-6 expression was increased in the cerebellum of
autistic subjects
Immunohistochemistry studies were conducted to exam-
ine IL-6 expression in the cerebellum of six autistic sub-
jects and six age matched controls using IL-6 antibody.
The results are shown in Figure 1. We observed that the
positive staining of IL-6 is obviously stronger in the cer-
ebellum of autistic subjects as compared with age-
matched controls. Quantitative analysis using Image J
showed that IL-6 is significantly increased by 89% in
autistic samples (p < 0.01).
In vitro adenoviral gene delivery
The in vitro experiments confirmed CGCs were effi-
ciently infected by an adenoviral vector carrying the
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was over than 90% (Figure 2).
IL-6 over-expression inhibited CGCs adhesion
To test the effect of IL-6 on adhesion of CGCs, CGCs
transfected with GFP tagged IL-6 viral vector (Ad-GFP-
IL-6) or GFP viral vector alone (Ad-GFP, used as a con-
trol) were seeded on the ICAM-1-coated surface. The
efficiency of cell adhesion was evaluated by a modified
MTS assay based on the dehydrogenase conversion of
MTS to colored tetrazolium salt, which occurs only in
viable cells that adhered to the substrate. The amount
of colored product formed at 490 nm (OD 490) was
proportional to the number of attached cells. As shown
in Figure 3, IL-6 inhibited cell adhesion by approxi-
mately 8% (p < 0.01, Figure 3).
IL-6 over-expression impaired granule cell migration
Cell migration is modulated by a complex of adhesion
molecules between migrating cells and surrounding
extracellular matrix (ECM) proteins, and critically
affected by cell adhesion [33]. Since we observed
decreased adhesion in IL-6 over-expressing cells, we
investigated whether IL-6 plays a role in CGC migration
with a modified Boyden chamber assay [34]. Our results
showed that the migration of IL-6-infected CGCs, like
cell adhesion, was also decreased by approximately 8%,
as compared with the controls (p = 0.01, Figure 4).
IL-6 had no detectable effect on the formation of
dentritic spines
To test whether over-expression of IL-6 affected dendri-
tic spine generation, DiI labelling was employed to show
Figure 1 IL-6 expression increased in the cerebellum of autistic subjects. Immunohistochemistry studies were carried out on cerebellar
homogenates from 6 autistic subjects and 6 age-matched controls using an IL-6 antibody (dilution 1:100). Stronger immunostaining of IL-6 (dark
brown color indicated by an arrow) was present in the autistic samples (a). Immunostaining density was quantified using Image J analysis (b).
Data are shown as mean ± SEM.
Figure 2 In vitro adenoviral gene delivery. The GFP expression on the CGCs shown after 24 h infection. The nuclei were labeled by TO-PRO-3
dye. Scale bar, 25 μm.
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of 12.40 ± 0.65 spines per 50 μm dendrite length, while
IL-6 CGCs showed a density of 10.50 ± 0.80 (p = 0.08,
Figure 5). These results indicate that IL-6 over-expres-
sion had no detectable effect on the formation of den-
dritic spines.
IL-6 over-expression did not promote granule cell
apoptosis
Granule cell apoptosis can be induced by various factors
and has been demonstrated both in vitro and in vivo
[35]. A group of inflammatory cytokines including TNF-
a,I F N - g and TGF-b have been suggested to initiate
apoptosis [36-40]. In order to determine whether IL-6 is
involved in the regulation of apoptosis, we stained cells
with TO-PRO-3 dye which can reveal the characteristic
morphology associated with apoptosis. TO-PRO-3 is sui-
ted as the nuclear staining dyes and an alternative to
Hoechst and DAPI, if a UV laser is not available [41,42].
As shown in Figure 6, no typical apoptotic CGCs were
observed in either control or IL-6 groups.
IL-6 stimulated the formation of excitatory synapses
Autism has been postulated to arise from functional
changes in neural circuitry and to be associated with an
imbalance between excitatory and inhibitory synaptic
transmission, but the mechanisms involved are unknown
[43]. To investigate whether an elevation of IL-6 could
have an effect on the proportion of excitatory or inhibi-
tory synapses, we examined the synapses formed in IL-6
and control CGCs by using antibodies to synaptic vesi-
cle proteins. An antibody to synaptophysin, a general
marker of all synapses, as well as antibodies to VGLUT1
(vesicular glutamate transporter), a marker of excitatory
synapses, and to VGAT (the vesicular GABA transpor-
ter), a marker of inhibitory synapses, were used in this
study (Figure 7). We observed a dramatic increase in
the intensity of Synaptophysin and VGLUT1 in IL-6
infected CGCs as compared to control cells (20% and
21% increase, respectively, Figure 7). In contrast, the
intensity of VGAT was not altered (Figure 7). These
data suggest that IL-6 stimulates the formation of exci-
tatory synapses, while having little effect on inhibitory
synapses.
Discussion
Localized CNS inflammation has been implicated in the
development of autism. Cytokines including TNF-a, IFN-
g,I L - 1 b and IL-12 have been reported to be elevated in
the blood mononuclear cells, serum and plasma of autistic
subjects [6,20-24]. Recent studies from our laboratory and
others have demonstrated that IL-6, IL-8, TNFa, TGF-b1
and MCP-1 are increased in frontal cortex, as well as in
the cerebrospinal fluid of autistic subjects [5,7,44]. In this
study we used immunohistochemistry to show that IL-6 is
significantly increased in the cerebellum of autistic brain
as compared with age and sex-matched normal controls.
Previously, a single study [7] examined the expression
level of IL-6 in the cerebellum of 7 autistic subjects and 7
controls using ELISA. The results from that study demon-
strated that the mean value of IL-6 was increased approxi-
mately 5 fold in the autistic cerebellum as compared with
controls. However due to a large variance in the sample,
this observation did not reach significance at the 0.05
l e v e l .O n ep o s s i b l es o u r c ef o rt h es i z eo ft h ev a r i a n c ei s
the selection criteria for the sample. Our results are based
on a sample with strictly age- and sex-matched controls,
Figure 3 IL-6 over-expression inhibited CGCs adhesion.
Comparision of CGCs adhesion between the control group and IL-6
group. The values are mean ± SEM from three independent
experiments. OD: optical density. **P < 0.01 compared with control
condition.
Figure 4 IL-6 over-expression impaired granule cell migration:
Modified Boyden chamber migration assays on IL-6 and control
CGCs. The number of migrated cells was determined by
fluorescence readings. The values are mean ± SEM from three
independent experiments. AFU: arbitrary fluorescence units. *P <
0.05 compared with control condition.
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contribute to the growing body of evidence that localized
CNS inflammation may contribute to the development of
autism.
An elevated cytokine response is associated with aut-
ism and IL-6 has been repeatedly found to be increased
in the autistic brain. In this study, we developed a
neural cell model of IL-6 over-expression with an ade-
noviral expression vector approach and examined the
effects of excessive IL-6 on neural cell properties and
functions. We showed that IL-6 over-expression in cul-
tured mouse cerebellar granule and microglial cells sig-
nificantly impaired neural cell migration and adhesion.
Neuronal migration is a fundamental process that deter-
mines the final location of neurons in the nervous sys-
tem, and thus establishes the basis for the subsequent
wiring of neural circuits. From cell polarization to target
identification, neuronal migration enables neuronal pre-
cursors to move across the brain to reach their final
destination by integrating multiple cellular and molecu-
lar events [33]. Thus, we suggest that increased IL-6
expression in the autistic brain could affect migration
and result in altered wiring of neural circuits. Cell
migration requires the dynamic regulation of adhesion
complexes between migrating cells and the surrounding
extracellular matrix [33]. In many cell types, this process
involves integrin-mediated adhesion [45-47]. Recently,
another study from our laboratory detected a compro-
mised Integrin b1/FAK/Src signaling in autistic lympho-
blasts and a significantly decreased migration of autistic
lymphoblasts [48]. Whether the inhibitory effect of IL-6
on granule cells migration and adhesion involves the
mediation of Integrin b1/FAK/Src signaling pathway
remains to be further investigated.
Emerging evidence points to an association of apopto-
sis with certain neuropsychiatric disorders including aut-
ism. Araghi-Niknam and Fatemi [49] demonstrated
altered levels of anti-apoptotic Bcl-2 and pro-apoptotic
Figure 5 IL-6 had little effect on the formation of dentritic spine. (a) Cultured CGCss were infected with IL-6 or control vector, and then
stained with Vybrant-DiI to outline the shape of dendritic spines. Arrowheads show the mature spines of mushroom-type. (b) The histogram
shows the density of mature spines per 50 μm dendrite in CGCs transfected with IL-6 (n = 10 neurons) or control vector (n = 8 neurons). The
data are the mean ± SEM. Scale bars, 5 μm.
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We also found that the Bcl-2 protein level is decreased
and the BDNF-Akt-Bcl-2 anti-apoptosis pathway is
down-regulated in the frontal cortex of autistic subjects
[10]. In addition, several studies have shown that apop-
tosis can be initiated by activation of a group of inflam-
matory cytokines, including TNF-a,I F N - g and TGF-b
[36-40]. Thus, we examined whether IL-6 over-expres-
sion promotes neural apoptosis. Our results showed that
IL-6 over-expression did not significantly enhance apop-
totic changes in the cultured granule cells. It is not clear
whether IL-6 is involved in the regulation of apoptosis-
related protein Bcl-2 and p53. However, our findings
imply that the increased IL-6 in autistic brain may not
be responsible for the possible apoptotic changes asso-
ciated with autism.
Synapses are asymmetric intercellular junctions that
mediate neuronal communication. The number, type,
and connectivity patterns of synapses determine the for-
mation, maintenance, and function of neural circuitries.
Improper synapse formation and function may cause
neurodevelopmental disorders, such as mental retarda-
tion and autism [50,51], and likely play a role in neuro-
degenerative disorders, such as Alzheimer’s disease [52].
The complexity and specificity of synaptogenesis relies
upon modulation of cell adhesion molecues (CAM),
that regulate contact initiation, synapse formation,
maturation, and plasticity. Disruption of adhesion may
result in structural and functional imbalance in
synapses. Surprisingly our in vitro studies showed that
increased IL-6 stimulates granule cell synapse forma-
tion, particularly enhanced excitatory synapse formation,
while it had little effect on inhibitory synapses. We also
demonstrated that IL-6 over-expression in granule cells
affected granule cell adhesion and migration, which sug-
gests that IL-6 could be involved in the regulation of
CAMs that critically modulate excitatory synaptic for-
mation. It will be important to further study the under-
lying mechanisms by which IL-6 affects the function of
CAMs and the way CAMs may be regulated by IL-6. A
number of studies have demonstrated that mutations in
the synaptic adhesion molecules neurexin 1 and neuroli-
gins 3 and 4 are associated with autism [51,53]. The
scaffolding molecule and interacting protein of neuroli-
gin SHANK3 has also been reported to be altered in
some autistic subjects [54,55]. These observations imply
an imbalance of neuronal circuitries in autism, which
could contribute to the development of the disorder.
Our findings, showing that IL-6 is increased in the
autistic brain and stimulates excitatory synaptic
Figure 6 IL-6 over-expression did not promote granule cell apoptosis. Representative images of labeling of TO-PRO-3 (blue) to show the
morphology of nuclear and MAP2 (red) in IL-6 and control CGCs, respectively. No typical apoptotic CGCs were observed in either control or IL-6
group. Scale bar, 25 μm.
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this hypothesis.
Conclusions
In conclusion, our study demonstrates that IL-6 was sig-
nificantly increased in the cerebellum of autistic subjects
as compared with age- and sex-matched controls. We
also showed that IL-6 over-expression in cerebellar
granule cells in vitro impaired granule cell adhesion and
migration. In addition, we found that IL-6 over-expres-
sion stimulated the formation of excitatory synapses of
granule cells, while having no effect on the inhibitory
synapses. These findings suggest that the elevated IL-6
in the autistic brain could cause an imbalance of neuro-
n a lc i r c u i t st h r o u g hi t se f f e c t so nn e u r a lc e l la d h e s i o n /
migration and synapse formation, and contribute to the
development of autism.
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